GENEQURE - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
86104198
Registration Number
4741698
Word Mark
GENEQURE
Status
710 - Cancelled - Section 8
Status Date
2021-12-03
Filing Date
2013-10-29
Registration Number
4741698
Registration Date
2015-05-26
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2014-09-30
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
COLEMAN, NICHOLAS A
Statements
Goods and Services
Viral assays, viral reagents, viral preparations, gene therapy assays, gene therapy reagents, gene therapy preparations, nucleic acid delivery assays, nucleic acid delivery reagents, nucleic acid delivery preparations, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors, all for non-medical research purposes
Goods and Services
Viral medicines, gene therapy medicines, nucleic acid delivery medicines, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors for medical purposes all for medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers; pharmaceutical preparations and substances for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy, all for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing in the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy in the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers
Goods and Services
Research, product development and consultancy in the field of biotechnology, biologics, pharmaceutics, medical science, chemistry and biochemistry
Goods and Services
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-12-03
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-12-03
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-12-03
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-12-03
Primary Code
044
Correspondences
Name
ZACHARY A. ARIA
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2013-09-18 | 12150091 | EM | True |
Trademark Events
| Event Date | Event Description |
| 2013-11-01 | NEW APPLICATION ENTERED IN TRAM |
| 2013-11-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2014-02-14 | ASSIGNED TO EXAMINER |
| 2014-02-23 | NON-FINAL ACTION WRITTEN |
| 2014-02-23 | NON-FINAL ACTION E-MAILED |
| 2014-02-23 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2014-07-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2014-07-25 | ASSIGNED TO LIE |
| 2014-07-25 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2014-07-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2014-08-06 | SUSPENSION LETTER WRITTEN |
| 2014-08-06 | LETTER OF SUSPENSION E-MAILED |
| 2014-08-06 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2014-08-08 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 2014-08-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2014-08-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2014-08-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2014-08-22 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2014-09-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2014-09-30 | PUBLISHED FOR OPPOSITION |
| 2014-09-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2014-11-25 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2014-12-01 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 2015-01-15 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2014-12-01 | NOTICE OF ALLOWANCE CANCELLED |
| 2015-01-20 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 2015-05-26 | REGISTERED-PRINCIPAL REGISTER |
| 2020-05-26 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 2021-12-03 | CANCELLED SEC. 8 (6-YR) |
